Royalty Pharma RPRX
NASDAQ RPRX
$57.63 -0.73 (-1.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Income from Continuing Operations (2019 - 2026)

Updated

Royalty Pharma (RPRX) reported Income from Continuing Operations of $81.49 million for Q2 2026, down 12.0% from $92.64 million a year earlier and down 82.6% from the prior quarter.

Analysis

Royalty Pharma (RPRX) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Royalty Pharma's Income from Continuing Operations came in at $1.35 billion, down 19.1% year-over-year; for FY2025, it was $1.32 billion, down 0.5% from FY2024.

  • Income from Continuing Operations has a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
  • By year, Income from Continuing Operations came in at $1.33 billion in FY2024 (-21.7%), $1.7 billion in FY2023 (+639.0%), $230.06 million in FY2022 (-81.5%) and $1.24 billion in FY2021 (-27.1%).
  • The Q2 2026 figure ranks as the lowest quarterly Income from Continuing Operations since Q1 2024.
  • Year over year, Income from Continuing Operations gained in three of the last seven quarters, with growth averaging 58.9%.
  • The high point for year-over-year Income from Continuing Operations in five years was Q3 2024 (growth of 560.5%); the low point was Q4 2021 (a decline of 85.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $468.26 million (Q1 2026), $355.91 million (Q4 2025) and $444.21 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Rocket Companies 43.26 Bn 28.94 Bn - 229.00 Mn
2 Orix 42.40 Bn 42.90 Bn - 1.76 Bn
3 Royalty Pharma 33.56 Bn 33.47 Bn - 81.49 Mn
4 Federal National Mortgage Association Fannie Mae 24.47 Bn 24.47 Bn - 3.98 Bn
5 Affirm Holdings 23.34 Bn 17.03 Bn - 1.62 Bn
6 Synchrony Financial 23.06 Bn -44.91 Bn - 885.00 Mn
7 Royal Gold 19.98 Bn 19.21 Bn 390.45 Mn 237.56 Mn
8 Annaly Capital Management 14.18 Bn 5.27 Bn - 827.77 Mn
9 Ares Capital 13.71 Bn 11.15 Bn - -
10 Federal Home Loan Mortgage 12.39 Bn -6.35 Bn - 3.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.49 Mn
Mar 31, 2026 468.26 Mn
Dec 31, 2025 355.91 Mn
Sep 30, 2025 444.21 Mn
Jun 30, 2025 92.64 Mn
Mar 31, 2025 434.43 Mn
Dec 31, 2024 334.35 Mn
Sep 30, 2024 806.36 Mn
Jun 30, 2024 194.38 Mn
Mar 31, 2024 -4.27 Mn
Dec 31, 2023 717.59 Mn
Sep 30, 2023 122.08 Mn
Jun 30, 2023 351.34 Mn
Mar 31, 2023 509.09 Mn
Dec 31, 2022 -610.03 Mn
Sep 30, 2022 220.41 Mn
Jun 30, 2022 491.60 Mn
Mar 31, 2022 128.08 Mn
Dec 31, 2021 53.67 Mn
Sep 30, 2021 221.80 Mn
API Access

Royalty Pharma Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RPRX&period=max&api_key=YOUR_API_KEY